Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Donaldson DCI stock worth starting a position in Q1 2026 Earnings Underperform GLXY Galaxy Digital Inc shares gain nearly six percent despite posting a wider than expected Q4 2025 per share loss What Allogene ALLO accounting reveals about the business Allogene Posts Smaller Loss Beats EPS Forecasts Airgain AIRG Stock Growth vs Risks Near Lows 20260420 WFC Wells reports modest Q1 2026 revenue growth edges past EPS estimates as shares dip slightly Dropbox DBX Stock Fair Value Stalls 20260420 MTBJ MT Bank releases limited quarterly earnings data with no core financial metrics available for investor review Vox Royalty VOXR Falls 301 Watching 582 Support 20260515 Biofrontera BFRI Q1 2026 Earnings Miss EPS 037 vs 012 Expected TIC Solutions TIC Q1 2026 Earnings Miss by Significant Key Takeaways Musk Slams OpenAI Trial Verdict as Technicality Vows to Appeal Terreno TRNO Stock Steady at 6533 Support at 6206 20260518 ViaSat VSAT Fell 544 Is a Recovery Ahead 20260515 TikToks Creator Economy A Surge in Discovery and Revenue for Businesses Genius Group Approves 100 Million AI Investment Strategy to Accelerate Growth Vestas Wind Systems Stock Slumps as Company Warns Margins May Hit Low End of Guidance Wix Announces 20 Workforce Reduction as CEO Addresses Industry Shift AMD Commits Over 10 Billion to Taiwan AI Market Expanding Chip Production and Partnerships Singapore Regulator Urges Banks to Accelerate Account Openings for Wealthy Clients Sweetgreen Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Okeanis Eco Tankers Corp Q1 2026 Earnings EPS Smashes Estimates by 3258 Despite Stock Dip KMPB Q1 2026 Earnings Significant Earnings Miss Raises Concerns for FixedRate Reset Debentures Five9 Q1 2026 Earnings EPS Surpasses Estimates by 913 as Stock Gains 421 CHCO Q1 2026 Earnings EPS Beat Amid Stable Operations RWAY Q1 2026 Earnings EPS Misses Estimates but Stock Gains as Portfolio Remains Resilient Clough Global Opportunities Fund GLO Edges Up 119 as It Tests Resistance at 627 Ocular Therapeutix OCUL Slips Slightly as Stock Holds Key Support at 775 Passage Bio PASG Holds Steady Near Support as Gene Therapy Sector Faces Crosscurrents Axsome Therapeutics AXSM Holds Near Resistance as Momentum Remains Cautious Silvercorp Metals SVM Slips 19 as Selling Pressure Tests Key Support Levels